Journal article · 2019

Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide

Fangqing Zhang, Zhenwei Wu, Pan Chen, Jian Zhang, Tao Wang, Jinpei Zhou, Huibin Zhang

Bioorganic & Medicinal Chemistry, 28(1), 115228 · Published 2 December 2019 · DOI 10.1016/j.bmc.2019.115228

View at the publisherCite this paper

In brief

“Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide” is a 2019 journal article by Fangqing Zhang and 6 co-authors, published in Bioorganic & Medicinal Chemistry. OpenAlex counts 51 citations as of 21 November 2026, which puts it in the top 3% of works published in 2019 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
51
Most cited in
2021 (10)
Field-weighted impact
1.44
References
26
Authors
7

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhang, F., Wu, Z., Chen, P., Zhang, J., Wang, T., Zhou, J., & Zhang, H. (2019). Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide. Bioorganic & Medicinal Chemistry, 28(1), 115228. https://doi.org/10.1016/j.bmc.2019.115228

MLA 9

Zhang, Fangqing, et al. “Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide.” Bioorganic & Medicinal Chemistry, vol. 28, no. 1, 2019, p. 115228. https://doi.org/10.1016/j.bmc.2019.115228.

Chicago

Zhang, Fangqing, Zhenwei Wu, Pan Chen, Jian Zhang, Tao Wang, Jinpei Zhou, and Huibin Zhang. 2019. “Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide.” Bioorganic & Medicinal Chemistry 28 (1): 115228. https://doi.org/10.1016/j.bmc.2019.115228.

Harvard

Zhang, F. et al. (2019) ‘Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide’, Bioorganic & Medicinal Chemistry, 28(1), p. 115228. doi:10.1016/j.bmc.2019.115228.

IEEE

F. Zhang et al., “Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide,” Bioorganic & Medicinal Chemistry, vol. 28, no. 1, p. 115228, 2019, doi: 10.1016/j.bmc.2019.115228.

BibTeX

@article{zhang2019discovery,
  title     = {{Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide}},
  author    = {Zhang, Fangqing and Wu, Zhenwei and Chen, Pan and Zhang, Jian and Wang, Tao and Zhou, Jinpei and Zhang, Huibin},
  journal   = {Bioorganic \& Medicinal Chemistry},
  year      = {2019},
  volume    = {28},
  number    = {1},
  pages     = {115228},
  doi       = {10.1016/j.bmc.2019.115228},
  url       = {https://doi.org/10.1016/j.bmc.2019.115228}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202055
20211010
202277
202377
202499
202577
202666

Its field-weighted citation impact is 1.44: it has been cited 1.44 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • BRD4
  • protein degradation
  • dihydroquinazolinones
  • lenalidomide
  • pomalidomide
  • cereblon E3 ligase
  • THP-1 cells

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhang, F., Wu, Z., Chen, P., Zhang, J., Wang, T., Zhou, J., & Zhang, H. (2019). Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone derivative and lenalidomide/pomalidomide. Bioorganic & Medicinal Chemistry, 28(1), 115228. https://doi.org/10.1016/j.bmc.2019.115228

How many times has this paper been cited?

51 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Fangqing Zhang, Zhenwei Wu, Pan Chen, Jian Zhang, Tao Wang, Jinpei Zhou, Huibin Zhang.

What is the DOI of this paper?

10.1016/j.bmc.2019.115228, permanently at https://doi.org/10.1016/j.bmc.2019.115228. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.